HIGHLIGHTS
- who: Ashley A. Stegelmeier and colleagues from the Department of Pathobiology, University of Guelph, Guelph, ON N G , Canada have published the Article: AAV-Vectored Expression of the Vascular Normalizing Agents 3TSR and Fc3TSR, and the Anti-Angiogenic Bevacizumab Extends Survival in a Murine Model of End-Stage Epithelial Ovarian Carcinoma, in the Journal: (JOURNAL)
- what: The aim of this study was to investigate whether sustained adeno-associated virus (AAV) vector-mediated expression of vascular 3TSR and Fc3TSR and the antiangiogenic monoclonal antibody Bevacizumab with or without oncolytic virus treatment would improve survival in an . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.